Efficacy of the female condom as a barrier to semen during intercourse

被引:63
作者
Macaluso, M
Lawson, ML
Hortin, G
Duerr, A
Hammond, KR
Blackwell, R
Bloom, A
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30341 USA
[2] Univ Alabama, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA
[3] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL 35294 USA
[4] Univ Alabama, Sch Med, Dept Obstet & Gynecol, Birmingham, AL 35294 USA
关键词
contraceptive devices; female; follow-up studies; safety; sexually transmitted diseases;
D O I
10.1093/aje/kwf212
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In 1996-1998, the authors measured prostate-specific antigen (PSA) in vaginal fluid to assess the frequency of female condom failure and to evaluate the association of self-reported failure with semen exposure. Women at low risk of sexually transmitted diseases (n = 210) were recruited in Birmingham, Alabama. They were trained to use the female condom, sample vaginal fluid before and after condom use, and complete forms to report problems during each use. Semen exposure was assessed by comparing pre- and postcoital PSA levels in vaginal fluid. A total of 175 women used 2,232 condoms. The rate of semen exposure ranged from 7% to 21% of condom uses, depending on the exposure criterion. Exposure was more likely (21-34%) and more intense (mean postcoital PSA, 24.7 ng/ml) if participants reported a mechanical problem versus other problems or no problems (exposure rate, 5-20% in both instances; mean postcoital PSA, 9 1 6 and 7.8 ng/ml, respectively). In logistic regression analyses for repeated measurements, user-reported problems accounted for less than 59% of the instances of semen exposure. The female condom prevented semen exposure in 79-93% of condom uses. Exposure was associated with user-reported problems but also occurred in their absence. Reported problems and semen exposure decreased with user experience.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 12 条
[1]   Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics [J].
Artz, L ;
Macaluso, M ;
Brill, I ;
Kelaghan, J ;
Austin, H ;
Fleenor, M ;
Robey, L ;
Hook, EW .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (02) :237-244
[2]   CONTRACEPTIVE EFFICACY AND ACCEPTABILITY OF THE FEMALE CONDOM [J].
FARR, G ;
GABELNICK, H ;
STURGEN, K ;
DORFLINGER, L .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (12) :1960-1964
[3]   Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial [J].
Fontanet, AL ;
Saba, J ;
Chandelying, V ;
Sakondhavat, C ;
Bhiraleus, P ;
Rugpao, S ;
Chongsomchai, C ;
Kiriwat, O ;
Tovanabutra, S ;
Dally, L ;
Lange, JM ;
Rojanapithayakorn, W .
AIDS, 1998, 12 (14) :1851-1859
[4]   POSTCOITAL DETECTION OF A MALE-SPECIFIC SEMEN PROTEIN - APPLICATION TO THE INVESTIGATION OF RAPE [J].
GRAVES, HCB ;
SENSABAUGH, GF ;
BLAKE, ET .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (06) :338-343
[5]   Objective markers of condom failure [J].
Lawson, ML ;
Maculuso, M ;
Bloom, A ;
Hortin, G ;
Hammond, KH ;
Blackwell, R .
SEXUALLY TRANSMITTED DISEASES, 1998, 25 (08) :427-432
[6]  
Littell R.C., 1996, SAS SYSTEM MIXED MOD, P423
[7]   Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure [J].
Macaluso, M ;
Lawson, L ;
Akers, R ;
Valappil, T ;
Hammond, K ;
Blackwell, R ;
Hortin, G .
CONTRACEPTION, 1999, 59 (03) :195-201
[8]   Mechanical failure of the latex condom in a cohort of women at high STD risk [J].
Macaluso, M ;
Kelaghan, J ;
Artz, L ;
Austin, H ;
Fleenor, M ;
Hook, EW ;
Valappil, T .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (08) :450-458
[9]   Female condom use among women at high risk of sexually transmitted disease [J].
Macaluso, M ;
Demand, M ;
Artz, L ;
Fleenor, M ;
Robey, L ;
Kelaghan, J ;
Cabral, R ;
Hook, EW .
FAMILY PLANNING PERSPECTIVES, 2000, 32 (03) :138-144
[10]  
SOPER D, 1993, SEX TRANSM DIS, V2, P137